Bliss GVS Pharma Ltd Share Price
(BLISSGVS)
₹131.3▲5.3%
as on 11:25AM, 24 Apr 2025
Bliss Gvs Performance
Day's Low
Day's High
₹123.44Day's Price Range₹133.452 Week's Low
52 Week's High
₹92.1552-Week Price Range₹185.5
| Returns % | |
| 1 Month Return | + 1.51 % |
| 3 Month Return | -22.78 % |
| 1 Year Return | + 7.68 % |
| Market Stats | |
| Previous Close | ₹124.69 |
| Open | ₹131.23 |
| Volume | 8.07L |
| Upper Circuit | ₹149.62 |
| Lower Circuit | ₹99.75 |
| Market Cap | ₹1,313.86Cr |
Bliss Gvs Fundamentals
P/E Ratio
21.99
PEG Ratio
-7.91
Market Cap
₹1,313.86 Cr
P/B Ratio
1.19
EPS
7.79
Dividend Yield
0.44
Sector
Pharmaceuticals
ROE
7.91
Mutual Fund Holdings of Bliss Gvs
| Funds | Holdings | Prev. 5M |
|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct Growth | 0.06% |
Key events for Bliss GVS Pharma Ltd
Bliss GVS Pharma Receives USFDA Approval for Mesalamine - 15 Apr, 2025
Bliss GVS Pharma's partner, Rising Pharma Holdings, has received USFDA approval for Mesalamine Suppositories 1000 mg. This approval enhances Bliss GVS's U.S. portfolio and reflects its growing R&D capabilities, addressing a niche market worth USD 29 million by January 2025.
Insights on Bliss GVS Pharma Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPromoter Holding Up
Promoters have increased holdings from 35.10% to 35.29% in Mar 2025 quarter
- POSITIVE IMPACT
Retail Holding Up
Retail Investor have increased holdings from 44.84% to 44.98% in Mar 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 187.77 Cr → 225.68 Cr (in ₹), with an average increase of 8.5% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 56.9% return, outperforming this stock by 47.1%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.6% return, outperforming this stock by 80.1%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, 24.26 Cr → 23.8 Cr (in ₹), with an average decrease of 1.9% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 months, BLISSGVS stock has moved down by -23.8%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 13.51% to 13.18% in Mar 2025 quarter
Bliss Gvs Financials
Bliss Gvs Index Inclusions
Bliss Gvs Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 35.29% | 0.00 | |
| Foreign Institutions | 13.18% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 44.98% | 0.00 | |
| Others | 6.55% | 0.00 |
Bliss Gvs Key Indicators
Bliss Gvs Valuation
Bliss Gvs in the last 5 years
Lowest (7.08x)
August 22, 2019
Today (21.99x)
April 23, 2025
Industry (53.87x)
April 23, 2025
Highest (576.11x)
January 3, 2022
Bliss Gvs Earnings and Dividends
Bliss GVS Pharma Ltd Earnings Results
Bliss GVS Pharma Ltd’s net profit fell -13.8% since last year same period to ₹23.80Cr in the Q3 2024-2025. On a quarterly growth basis, Bliss GVS Pharma Ltd has generated -1.9% fall in its net profits since last 3-months.
Read More about Earnings ResultsBliss GVS Pharma Ltd Dividends May,2024
In the quarter ending March 2024, Bliss GVS Pharma Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.80%.
Read More about Dividends
Bliss Gvs Technicals Summary
Bearish
Neutral
Bullish
Bliss GVS Pharma Ltd is currently in a Bullish trading position according to technical analysis indicators.
Bliss Gvs Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹1,313.86 Cr | 5.19% | 0.54 | ₹81 Cr | ₹770 Cr | |
| NA | ₹11.15 Cr | 66.72% | 0.50 | NA | NA | |
| NA | ₹2,987.44 Cr | 39.26% | 0.53 | ₹96 Cr | ₹1,690 Cr | |
| NA | ₹520.52 Cr | 260.56% | 0.73 | ₹7 Cr | ₹1 Cr | |
| NA | ₹157.93 Cr | 105.19% | 0.69 | NA | NA |
About Bliss Gvs
Bliss GVS Pharma has a successful history, with various achievements over the years, such as investment in 51 share capital of Lifeon Labs Pvt Ltd. and the formation of a new company, Asterisk Lifesciences Limited, as a wholly owned foreign subsidiary in the UK for registrations and marketing in Europe. The company has also procured a USD 111.40 million contract from Aon.
To further its growth, Bliss GVS Pharma divested three subsidiaries and one stepdown subsidiary in 2018. The company also invested in a new 200,000 sq. ft. multiproduct facility in Maharashtra, equipped with state-of-the-art process equipment and utilities. In the financial year 2019-2020, the company had 4 wholly owned subsidiaries and 3 stepdown subsidiaries.
Revenue: ₹210.42Cr as on December 2024 (Q4 24)
Net Profit: ₹25.80Cr as on December 2024 (Q4 24)
Listing date: 26 Jul, 2010
Chairperson Name: Subramanian R Vaidya
| Organisation | Bliss Gvs |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Bliss GVS Pharma Ltd
What is Bliss GVS Pharma Ltd price today?
Bliss GVS Pharma Ltd share price today stands at ₹131.3, Open: ₹131.23, Previous Close: ₹124.69, High: ₹133.4, Low: ₹123.44, 52 Week High: ₹185.5, 52 Week Low: ₹92.15.
How to Buy Bliss GVS Pharma Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Bliss GVS Pharma Ltd shares
What are today's traded volumes of Bliss GVS Pharma Ltd?
Today's traded volume of Bliss GVS Pharma Ltd(BLISSGVS) is 8.07L.
What is today's market capitalisation of Bliss GVS Pharma Ltd?
Today's market capitalisation of Bliss GVS Pharma Ltd(BLISSGVS) is ₹1313.86Cr.
What is the 52 Week High and Low Range of Bliss GVS Pharma Ltd?
How much percentage Bliss GVS Pharma Ltd is down from its 52 Week High?
Bliss GVS Pharma Ltd (BLISSGVS) share price is ₹131.3. It is down -29.22% from its 52 Week High price of ₹185.5
How much percentage Bliss GVS Pharma Ltd is up from its 52 Week low?
Bliss GVS Pharma Ltd (BLISSGVS) share price is ₹131.3. It is up 42.49% from its 52 Week Low price of ₹92.15